臓器保存技術の世界市場見通し2023年-2029年

◆英語タイトル:Organ Preservation Technology Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23FB2214)◆商品コード:MMG23FB2214
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年2月
◆ページ数:61
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の臓器保存技術市場規模と予測を収録しています。・世界の臓器保存技術市場:売上、2018年-2023年、2024年-2029年
・世界の臓器保存技術市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の臓器保存技術市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「静的冷蔵保存(SCS)」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

臓器保存技術のグローバル主要企業は、BioLife Solutions、Dr. Franz Köhler Chemie GmbH、21st Century Medicine、Bridge to Life Limited、Teva Pharmaceuticals、Lifeline Scientific、、XVIVO Perfusion、Artivion、Preservation Solutions、Bristol Myers Squibb、Accord Healthcare、Advanced Life Solutions、Organ Recovery Systems、Transmedicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、臓器保存技術のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の臓器保存技術市場:タイプ別、2018年-2023年、2024年-2029年
世界の臓器保存技術市場:タイプ別市場シェア、2022年
・静的冷蔵保存(SCS)、低体温灌流保存(HPP)、低体温機械保存(HMP)、その他

世界の臓器保存技術市場:用途別、2018年-2023年、2024年-2029年
世界の臓器保存技術市場:用途別市場シェア、2022年
・腎臓、肝臓、心臓、肺、その他

世界の臓器保存技術市場:地域・国別、2018年-2023年、2024年-2029年
世界の臓器保存技術市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における臓器保存技術のグローバル売上、2018年-2023年
・主要企業における臓器保存技術のグローバル売上シェア、2022年
・主要企業における臓器保存技術のグローバル販売量、2018年-2023年
・主要企業における臓器保存技術のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
BioLife Solutions、Dr. Franz Köhler Chemie GmbH、21st Century Medicine、Bridge to Life Limited、Teva Pharmaceuticals、Lifeline Scientific、、XVIVO Perfusion、Artivion、Preservation Solutions、Bristol Myers Squibb、Accord Healthcare、Advanced Life Solutions、Organ Recovery Systems、Transmedics

*************************************************************

・調査・分析レポートの概要
臓器保存技術市場の定義
市場セグメント
世界の臓器保存技術市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の臓器保存技術市場規模
世界の臓器保存技術市場規模:2022年 VS 2029年
世界の臓器保存技術市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの臓器保存技術の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の臓器保存技術製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:静的冷蔵保存(SCS)、低体温灌流保存(HPP)、低体温機械保存(HMP)、その他
臓器保存技術のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:腎臓、肝臓、心臓、肺、その他
臓器保存技術の用途別グローバル売上・予測

・地域別市場分析
地域別臓器保存技術市場規模 2022年と2029年
地域別臓器保存技術売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
BioLife Solutions、Dr. Franz Köhler Chemie GmbH、21st Century Medicine、Bridge to Life Limited、Teva Pharmaceuticals、Lifeline Scientific、、XVIVO Perfusion、Artivion、Preservation Solutions、Bristol Myers Squibb、Accord Healthcare、Advanced Life Solutions、Organ Recovery Systems、Transmedics
...

This report aims to provide a comprehensive presentation of the global market for Organ Preservation Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Preservation Technology. This report contains market size and forecasts of Organ Preservation Technology in global, including the following market information:
Global Organ Preservation Technology Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Organ Preservation Technology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Static Cold Storage (SCS) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Organ Preservation Technology include BioLife Solutions, Dr. Franz Köhler Chemie GmbH, 21st Century Medicine, Bridge to Life Limited, Teva Pharmaceuticals, Lifeline Scientific
, XVIVO Perfusion, Artivion and Preservation Solutions, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Organ Preservation Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Organ Preservation Technology Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Organ Preservation Technology Market Segment Percentages, by Type, 2022 (%)
Static Cold Storage (SCS)
Hypothermic Perfusion Preservation (HPP)
Hypothermic Machine Preservation (HMP)
Others
Global Organ Preservation Technology Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Organ Preservation Technology Market Segment Percentages, by Application, 2022 (%)
Kidney
Liver
Heart
Lung
Others
Global Organ Preservation Technology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Organ Preservation Technology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Organ Preservation Technology revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Organ Preservation Technology revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioLife Solutions
Dr. Franz Köhler Chemie GmbH
21st Century Medicine
Bridge to Life Limited
Teva Pharmaceuticals
Lifeline Scientific

XVIVO Perfusion
Artivion
Preservation Solutions
Bristol Myers Squibb
Accord Healthcare
Advanced Life Solutions
Organ Recovery Systems
Transmedics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Organ Preservation Technology, market overview.
Chapter 2: Global Organ Preservation Technology market size in revenue.
Chapter 3: Detailed analysis of Organ Preservation Technology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Organ Preservation Technology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Organ Preservation Technology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Organ Preservation Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Organ Preservation Technology Overall Market Size
2.1 Global Organ Preservation Technology Market Size: 2022 VS 2029
2.2 Global Organ Preservation Technology Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Organ Preservation Technology Players in Global Market
3.2 Top Global Organ Preservation Technology Companies Ranked by Revenue
3.3 Global Organ Preservation Technology Revenue by Companies
3.4 Top 3 and Top 5 Organ Preservation Technology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Organ Preservation Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Organ Preservation Technology Players in Global Market
3.6.1 List of Global Tier 1 Organ Preservation Technology Companies
3.6.2 List of Global Tier 2 and Tier 3 Organ Preservation Technology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Organ Preservation Technology Market Size Markets, 2022 & 2029
4.1.2 Static Cold Storage (SCS)
4.1.3 Hypothermic Perfusion Preservation (HPP)
4.1.4 Hypothermic Machine Preservation (HMP)
4.1.5 Others
4.2 By Type – Global Organ Preservation Technology Revenue & Forecasts
4.2.1 By Type – Global Organ Preservation Technology Revenue, 2018-2023
4.2.2 By Type – Global Organ Preservation Technology Revenue, 2024-2029
4.2.3 By Type – Global Organ Preservation Technology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Organ Preservation Technology Market Size, 2022 & 2029
5.1.2 Kidney
5.1.3 Liver
5.1.4 Heart
5.1.5 Lung
5.1.6 Others
5.2 By Application – Global Organ Preservation Technology Revenue & Forecasts
5.2.1 By Application – Global Organ Preservation Technology Revenue, 2018-2023
5.2.2 By Application – Global Organ Preservation Technology Revenue, 2024-2029
5.2.3 By Application – Global Organ Preservation Technology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Organ Preservation Technology Market Size, 2022 & 2029
6.2 By Region – Global Organ Preservation Technology Revenue & Forecasts
6.2.1 By Region – Global Organ Preservation Technology Revenue, 2018-2023
6.2.2 By Region – Global Organ Preservation Technology Revenue, 2024-2029
6.2.3 By Region – Global Organ Preservation Technology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Organ Preservation Technology Revenue, 2018-2029
6.3.2 US Organ Preservation Technology Market Size, 2018-2029
6.3.3 Canada Organ Preservation Technology Market Size, 2018-2029
6.3.4 Mexico Organ Preservation Technology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Organ Preservation Technology Revenue, 2018-2029
6.4.2 Germany Organ Preservation Technology Market Size, 2018-2029
6.4.3 France Organ Preservation Technology Market Size, 2018-2029
6.4.4 U.K. Organ Preservation Technology Market Size, 2018-2029
6.4.5 Italy Organ Preservation Technology Market Size, 2018-2029
6.4.6 Russia Organ Preservation Technology Market Size, 2018-2029
6.4.7 Nordic Countries Organ Preservation Technology Market Size, 2018-2029
6.4.8 Benelux Organ Preservation Technology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Organ Preservation Technology Revenue, 2018-2029
6.5.2 China Organ Preservation Technology Market Size, 2018-2029
6.5.3 Japan Organ Preservation Technology Market Size, 2018-2029
6.5.4 South Korea Organ Preservation Technology Market Size, 2018-2029
6.5.5 Southeast Asia Organ Preservation Technology Market Size, 2018-2029
6.5.6 India Organ Preservation Technology Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Organ Preservation Technology Revenue, 2018-2029
6.6.2 Brazil Organ Preservation Technology Market Size, 2018-2029
6.6.3 Argentina Organ Preservation Technology Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Organ Preservation Technology Revenue, 2018-2029
6.7.2 Turkey Organ Preservation Technology Market Size, 2018-2029
6.7.3 Israel Organ Preservation Technology Market Size, 2018-2029
6.7.4 Saudi Arabia Organ Preservation Technology Market Size, 2018-2029
6.7.5 UAE Organ Preservation Technology Market Size, 2018-2029
7 Organ Preservation Technology Companies Profiles
7.1 BioLife Solutions
7.1.1 BioLife Solutions Company Summary
7.1.2 BioLife Solutions Business Overview
7.1.3 BioLife Solutions Organ Preservation Technology Major Product Offerings
7.1.4 BioLife Solutions Organ Preservation Technology Revenue in Global Market (2018-2023)
7.1.5 BioLife Solutions Key News & Latest Developments
7.2 Dr. Franz Köhler Chemie GmbH
7.2.1 Dr. Franz Köhler Chemie GmbH Company Summary
7.2.2 Dr. Franz Köhler Chemie GmbH Business Overview
7.2.3 Dr. Franz Köhler Chemie GmbH Organ Preservation Technology Major Product Offerings
7.2.4 Dr. Franz Köhler Chemie GmbH Organ Preservation Technology Revenue in Global Market (2018-2023)
7.2.5 Dr. Franz Köhler Chemie GmbH Key News & Latest Developments
7.3 21st Century Medicine
7.3.1 21st Century Medicine Company Summary
7.3.2 21st Century Medicine Business Overview
7.3.3 21st Century Medicine Organ Preservation Technology Major Product Offerings
7.3.4 21st Century Medicine Organ Preservation Technology Revenue in Global Market (2018-2023)
7.3.5 21st Century Medicine Key News & Latest Developments
7.4 Bridge to Life Limited
7.4.1 Bridge to Life Limited Company Summary
7.4.2 Bridge to Life Limited Business Overview
7.4.3 Bridge to Life Limited Organ Preservation Technology Major Product Offerings
7.4.4 Bridge to Life Limited Organ Preservation Technology Revenue in Global Market (2018-2023)
7.4.5 Bridge to Life Limited Key News & Latest Developments
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Company Summary
7.5.2 Teva Pharmaceuticals Business Overview
7.5.3 Teva Pharmaceuticals Organ Preservation Technology Major Product Offerings
7.5.4 Teva Pharmaceuticals Organ Preservation Technology Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceuticals Key News & Latest Developments
7.6 Lifeline Scientific

7.6.1 Lifeline Scientific
Company Summary
7.6.2 Lifeline Scientific
Business Overview
7.6.3 Lifeline Scientific
Organ Preservation Technology Major Product Offerings
7.6.4 Lifeline Scientific
Organ Preservation Technology Revenue in Global Market (2018-2023)
7.6.5 Lifeline Scientific
Key News & Latest Developments
7.7 XVIVO Perfusion
7.7.1 XVIVO Perfusion Company Summary
7.7.2 XVIVO Perfusion Business Overview
7.7.3 XVIVO Perfusion Organ Preservation Technology Major Product Offerings
7.7.4 XVIVO Perfusion Organ Preservation Technology Revenue in Global Market (2018-2023)
7.7.5 XVIVO Perfusion Key News & Latest Developments
7.8 Artivion
7.8.1 Artivion Company Summary
7.8.2 Artivion Business Overview
7.8.3 Artivion Organ Preservation Technology Major Product Offerings
7.8.4 Artivion Organ Preservation Technology Revenue in Global Market (2018-2023)
7.8.5 Artivion Key News & Latest Developments
7.9 Preservation Solutions
7.9.1 Preservation Solutions Company Summary
7.9.2 Preservation Solutions Business Overview
7.9.3 Preservation Solutions Organ Preservation Technology Major Product Offerings
7.9.4 Preservation Solutions Organ Preservation Technology Revenue in Global Market (2018-2023)
7.9.5 Preservation Solutions Key News & Latest Developments
7.10 Bristol Myers Squibb
7.10.1 Bristol Myers Squibb Company Summary
7.10.2 Bristol Myers Squibb Business Overview
7.10.3 Bristol Myers Squibb Organ Preservation Technology Major Product Offerings
7.10.4 Bristol Myers Squibb Organ Preservation Technology Revenue in Global Market (2018-2023)
7.10.5 Bristol Myers Squibb Key News & Latest Developments
7.11 Accord Healthcare
7.11.1 Accord Healthcare Company Summary
7.11.2 Accord Healthcare Business Overview
7.11.3 Accord Healthcare Organ Preservation Technology Major Product Offerings
7.11.4 Accord Healthcare Organ Preservation Technology Revenue in Global Market (2018-2023)
7.11.5 Accord Healthcare Key News & Latest Developments
7.12 Advanced Life Solutions
7.12.1 Advanced Life Solutions Company Summary
7.12.2 Advanced Life Solutions Business Overview
7.12.3 Advanced Life Solutions Organ Preservation Technology Major Product Offerings
7.12.4 Advanced Life Solutions Organ Preservation Technology Revenue in Global Market (2018-2023)
7.12.5 Advanced Life Solutions Key News & Latest Developments
7.13 Organ Recovery Systems
7.13.1 Organ Recovery Systems Company Summary
7.13.2 Organ Recovery Systems Business Overview
7.13.3 Organ Recovery Systems Organ Preservation Technology Major Product Offerings
7.13.4 Organ Recovery Systems Organ Preservation Technology Revenue in Global Market (2018-2023)
7.13.5 Organ Recovery Systems Key News & Latest Developments
7.14 Transmedics
7.14.1 Transmedics Company Summary
7.14.2 Transmedics Business Overview
7.14.3 Transmedics Organ Preservation Technology Major Product Offerings
7.14.4 Transmedics Organ Preservation Technology Revenue in Global Market (2018-2023)
7.14.5 Transmedics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 臓器保存技術の世界市場見通し2023年-2029年(Organ Preservation Technology Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。